Skip to main content

Table 1 Patients characteristics

From: The relationship between tumor-infiltrating neutrophils and clinical outcomes in patients with resectable hepatocellular carcinoma

Variables

Total = 115

Age (years), n (%)

 < 60

64 (55.7)

 ≥ 60

51 (44.3)

Gender, n (%)

 Female

23 (20.0)

 Male

92 (80.0)

Etiology, n (%)

 HBV

92 (80.0)

 Others

23 (20.0)

AFP (ng/mL), n (%)

 < 100

64 (55.7)

 ≥ 100

51 (44.3)

Tumor size (cm), n (%)

 ≤ 3

57 (49.6)

 < 3 ~ ≤ 5

24 (20.9)

 > 5

34 (29.6)

Tumor number, n (%)

 Single

106 (92.2)

 Multiple

9 (7.8)

TMN stage, n (%)

 I

18 (15.7)

 II

52 (45.2)

 III

45 (39.1)

BCLC stage, n (%)

 0/A

76 (66.1)

 B/C

39 (33.9)

ES grade, n (%)

 Well/Moderate

50 (43.5)

 Poor

65 (56.5)

Vascular invasion, n (%)

 Absent

83 (72.2)

 Present

32 (27.8)

Underlying cirrhosis, n (%)

 Absent

42 (36.5)

 Present

73 (63.5)

  1. AFP Alpha-fetoprotein, BCLC Barcelona Clinic Liver Cancer, ES Edmondson and Steiner